Another test for 2009 H1N1 influenza virus

U.S. Food and Drug Administration (FDA) Authorizes Emergency Use of Another Test for 2009 H1N1 Influenza Virus – The U.S. Food and Drug Administration announced it has issued an Emergency Use Authorization (EUA) for a another diagnostic test for the 2009 H1N1 influenza virus, whose spread has caused the virus to be characterized as a pandemic by the World Health Organization.

HIV progresses faster in women than in men

Study may explain why HIV progresses faster in women than in men with same viral load — Pathways related to elevated immune activation could lead to new treatment strategies. – One of the continuing mysteries of the HIV/AIDS epidemic is why women usually develop lower viral levels than men following acute HIV-1 infection but progress faster to AIDS than men with similar viral loads.

AIDS virus damages gut antibody-producing immune cells

HIV-1 damages gut antibody-producing immune cells within days of infection – A new research from the NIAID-funded Center for HIV/AIDS Vaccine Immunology suggests that HIV-1 is anything but ? moving at breathtaking speed in destroying and dysregulating the body’s gut-based B-cell antibody-producing system.

Combined antiviral and chemotherapy to fight HIV AIDS

A new weapon in the war against HIV-AIDS: Combined antiviral and targeted chemotherapy – HIV-AIDS could be treated through a combination of targeted chemotherapy and current Highly Active Retroviral (HAART) treatments, revealed by researchers.

Low cost HIV monitoring test gives result in 30 min

Australian scientists develop a new low-cost, point-of-care HIV monitoring treatment – Scientists at the Burnet Institute, Australia’s leading medical research and public health institute focused on infectious diseases, have developed a prototype low-cost HIV monitoring test designed for field use in remote settings.

Besivance eye drop approved to treat bacterial conjunctivitis

U.S. Food and Drug Administration (FDA) Approves Besivance to Treat Bacterial Conjunctivitis – The U.S. Food and Drug Administration approved Besivance (besifloxacin ophthalmic suspension 0.6 percent) for the treatment of bacterial conjunctivitis (non-viral), a contagious condition marked by irritation of the eyes and a discharge from the mucous membranes.

AIDS Action observes HIV vaccine awareness day

AIDS Action Statement on HIV Vaccine Awareness Day: Reason to Hope. – Every nine and a half minutes someone in the United States is infected with HIV. The Centers for Disease Control and Prevention (CDC) estimates that approximately 56,300 individuals became infected with HIV in 2006 alone.

High blood pressure from virus cytomegalovirus

Study indicates that a common virus could cause high blood pressure – Cytomegalovirus affects majority of adults worldwide. – A new study suggests for the first time that cytomegalovirus (CMV), a common viral infection affecting between 60 and 99 percent of adults worldwide, is a cause of high blood pressure, a leading risk factor for heart disease, stroke and kidney disease.

AIDS patients get benefit from early retroviral use

AIDS patients with serious complications benefit from early retroviral use, Stanford study shows – HIV-positive patients who don’t seek medical attention until they have a serious AIDS-related condition can reduce their risk of death or other complications by half if they get antiretroviral treatment early on, according to a new multicenter trial led by researchers at the Stanford University School of Medicine.

$45 million for infectious disease research, UCI

UCI awarded $45 million for infectious disease research. Facility seeks to improve detection, treatment and vaccine development. – The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded UC Irvine $45 million over five years for infectious disease research.

Herpes medication does not reduce HIV transmission risk

Study demonstrates modest reduction in HIV disease progression, leads to new insights about HIV transmission. – A recently completed international multi-center clinical trial has found that acyclovir, a drug widely used as a safe and effective treatment to suppress herpes simplex virus-2 (HSV-2), which is the most common cause of genital herpes, does not reduce the risk of HIV transmission when taken by people infected with both HIV and HSV-2.

Avoid nonessential travel to Mexico

Swine flu screening has been instituted at airports and land borders for travelers departing Mexico, according to Mexican health authorities. – CDC is concerned that continued travel by U.S. travelers to Mexico presents a serious risk for further outbreaks of swine flu in the United States. At this time, CDC recommends that U.S. travelers avoid all nonessential travel to Mexico.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | SpiritIndia